statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition

Aditxt, Inc. (Aditxt) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, and its wholly-owned subsidiary, Adivir, Inc., have entered into a...

Evofem Signs Phexxi License Agreement for Middle East with Pharma 1

Evofem Signs Phexxi License Agreement for Middle East with Pharma 1 Evofem Signs Phexxi License Agreement for Middle East with Pharma 1 PR Newswire SAN DIEGO, July 23, 2024 Pharma 1 anticipates...

What's Going On With Aditxt Shares Wednesday?

Aditxt and Evofem amended and restated their merger agreement.
read more...

Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing

Aditxt, Inc. (Aditxt) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, announces this past Friday, July 12th, Aditxt, its wholly owned...

Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC

Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC PR Newswire...

Hello Alpha Partners with Evofem to Offer Phexxi as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare

Hello Alpha Partners with Evofem to Offer Phexxi as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare Hello Alpha Partners with Evofem to Offer Phexxi as a Hormone-Free...

Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter

Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter PR Newswire SAN DIEGO, June 11...

Evofem Biosciences Announces Financial Results for the First Quarter of 2024

Evofem Biosciences Announces Financial Results for the First Quarter of 2024 Evofem Biosciences Announces Financial Results for the First Quarter of 2024 PR Newswire SAN DIEGO, May 15, 2024 SAN...

Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. (NASDAQ: ADTX) (Aditxt or the Company), a company dedicated to discovering, developing, and deploying promising health innovations, today announced that it has entered into securities...

Aditxt  in pact to acquire Appili Therapeutics for 5.6c per share

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.

Volume	185,532.00
52-Wk High	$68.08
52-Wk Low	$1.30

ADTX Aditxt Inc

About

Feed

News

Fundamentals